Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
Hospital Regional Universitario de Málaga
Málaga, EspañaPublications en collaboration avec des chercheurs de Hospital Regional Universitario de Málaga (26)
2024
2023
-
Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries
Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690
-
The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids
Chest, Vol. 164, Núm. 3, pp. 606-613
-
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
Cancers, Vol. 15, Núm. 4
2022
-
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
Haematologica, Vol. 107, Núm. 11, pp. 2675-2684
-
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes
Biomedicines, Vol. 10, Núm. 5
-
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21
-
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis
Journal of Clinical Medicine, Vol. 11, Núm. 14
-
Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19 results of the UMC-19-S12
Journal of Clinical Gastroenterology, Vol. 56, Núm. 1, pp. E38-E46
-
Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
Biomolecules, Vol. 12, Núm. 10
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
-
Safety and Revisit Related to Discharge the Sixty-one Spanish Emergency Department Medical Centers Without Hospitalization in Patients with COVID-19 Pneumonia. A Prospective Cohort Study UMC-Pneumonia COVID-19
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, Vol. 74, Núm. 3, pp. 135-146
-
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study
Biomedicines, Vol. 10, Núm. 2
2021
-
A case-control analysis of stroke in COVID-19 patients: Results of unusual manifestations of COVID-19–study 11
Academic Emergency Medicine, Vol. 28, Núm. 11, pp. 1236-1250
-
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27
-
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
International Journal of Cardiology, Vol. 330, pp. 268-272
-
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis
Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434
-
RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 28-35
2020
2019
-
Comparison of different strategies for short-term death prediction in the infected older patient
Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 156-164